Carlos Perez-Albuerne on 510(k) in Patent Litigation
View "510(k) In Patent Litigation: Applicants Should Be Cautious"
Carlos Perez-Albuerne wrote “510(k) In Patent Litigation: Applicants Should Be Cautious,” in Intellectual Property Law360 where he discusses the intersection of medical device manufacturer’s patent strategies with their regulatory approval process. He also examines the risks manufacturers take when utilizing the accelerated approval process outlined in Section 510(k) of the Food, Drug and Cosmetic Act. The article also appeared in Life Sciences Law360.